Tag: Academic publishing

OCLC Says ‘What Is Known Must Be Shared,’ But Is Suing Anna’s Archive For Sharing Knowledge

Tina Marie (Ms. Cat)
How do you think I get most of my Ebooks?! 😉

Back in March, Walled Culture wrote about the terrible job that academic publishers are doing in terms of creating backups of the articles they publish.  We also mentioned there two large-scale archives that are trying to help, Sci-Hub and Anna’s Archive.  Legal action by publishers against the former seems to have led to a halt to new items being added to its collection.  This has resulted in the rise of Anna’s Archive as the main large-scale archive of academic papers and other material.  It has also led to a lawsuit against the site, as TorrentFreak reports.  The legal move is by the non-profit OCLC, which was originally the Ohio College Library Center, then became the Online Computer Library Center, and is now simply OCLC.  It describes itself as follows:

OCLC Says ‘What Is Known Must Be Shared,’ But Is Suing Anna’s Archive For Sharing Knowledge

Related:

Anna’s Archive

Alternative site 1

Alternative site 2

Note: I’m not a fan of copyright. Any information inside my documents is free to use. If it’s an article or a blog post that I’ve written, please ask for my permission before using it.

Scientific Misconduct and Fraud: The Final Nail in Psychiatry’s Antidepressant Coffin

Tina Marie (Ms. Cat)

“. . . if the major media picks up on this story, they will have the chance to report on what arguably is the worst—and most harmful—scandal in American medical history”

Robert Whitaker, publisher of madinamerica.com, January 3, 2024

Historically, there have always been some patients who report that any treatment for depression—including bloodletting—has worked for them, but science demands that for a treatment to be deemed truly effective, it must work better than a placebo or the passage of time without any treatment. This is especially important for antidepressant drugs—including Prozac, Zoloft, and other selective serotonin reuptake inhibitors (SSRIs), as well as Effexor, Cymbalta, and other serotonin and norepinephrine reuptake inhibitors (SNRIs)—because all of these drugs have uncontroversial troubling side effects.

Scientific Misconduct and Fraud: The Final Nail in Psychiatry’s Antidepressant Coffin

Related:

Once Radical Critiques of Psychiatry are Now Mainstream, So What Remains Taboo?

Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next

Censorship at the American Psychological Association

Tina Marie (Ms. Cat)

The publishing process in academic psychology journals isn’t typically known for its drama or intrigue. It’s true that there can be frustrations and challenges for aspiring authors. These include obtaining timely feedback from peer reviewers; adequately addressing often-disparate concerns and revision recommendations; and waiting the many months that frequently elapse between submitting a manuscript and its hoped-for publication. Nevertheless, there’s little doubt that articles published in reputable scientific journals play an essential role in advancing our understanding of human behavior.

Censorship at the American Psychological Association